Trial Profile
Extra-fine beclometasone/formoterol and non-extra-fine salmeterol/fluticasone propionate in patients with moderate persistent asthma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.